Wells Fargo upgraded CVS Health (CVS) to Overweight from Equal Weight with a price target of $66, up from $60.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CVS:
- CVS Health price target lowered to $58 from $68 at RBC Capital
- McKesson, Oracle among finalists looking to buy Veradigm, Axios reports
- CVS Health price target lowered to $71 from $75 at Barclays
- CVS Health’s (CVS) New CEO Announces Leadership Changes amid Challenges at Aetna
- CVS Health Corp Reports Q3 2024 Earnings